1. YUPELRI [package insert]. Morgantown, WV: Mylan Specialty LP.
  2. Gardenhire DS, Burnett D, Strickland S, Myers TR. A Guide to Aerosol Delivery Devices for Respiratory Therapists. 4th ed. Irving, TX: American Association for Respiratory Care; 2017.
  3. Hanania NA, Braman S, Adams SG, et al. The role of inhalation delivery devices in COPD: perspectives of patients and health care providers. Chronic Obstr Pulm Dis. 2018;5(2):111-123.
  4. Dhand R, Dolovich M, Chipps B, et al. The role of nebulized therapy in the management of COPD: evidence and recommendations. COPD. 2012;9(1):58-72.
  5. Dolovich MB, Dhand R. Aerosol drug delivery: developments in device design and clinical use. Lancet. 2011;377(9770):1032-1045.
  6. Ibrahim M, Verma R, Garcia-Contreras L. Inhalation drug delivery devices: technology update. Med Devices (Auckl). 2015;8:131-139.
  7. Martin AR, Finlay WH. Nebulizers for drug delivery to the lungs. Expert Opin Drug Deliv. 2014;12(6):889-900.
  8. Wise RA, Acevedo RA, Anzueto AR, et al. Guiding principles for the use of nebulized long-acting beta2-agonists in patients with COPD: an expert panel consensus. Chronic Obstr Pulm Dis. 2016;4(1):7-20.
  9. Dhand R, Cavanaugh T, Skolnik N. Considerations for optimal inhaler device selection in chronic obstructive pulmonary disease. Cleve Clin J Med. 2018;85(2 suppl 1):S19-S27.
  10. Taffet GE, Donohue JF, Altman PR. Considerations for managing chronic obstructive pulmonary disease in the elderly. Clin Interv Aging. 2014;9:23-30.
  11. Data on file.
  12. Schnell K, Weiss CO, Lee T, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med. 2012;12:26.
  13. Mahler DA, Waterman LA, Gifford AH. J Aerosol Med Pulm Drug Deliv. 2013;26(3):174-179.
  14. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report). Accessed January 26, 2023.
  15. Sulaiman I, Cushen B, Greene G, et al. Objective assessment of adherence to inhalers by patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(10):1333-1343.
  16. Schure MB, Borson S, Nguyen HQ, et al. Associations of cognition with physical functioning and health-related quality of life among COPD patients. Respir Med. 2016;114:46-52.
  17. Baird C, Lovell J, Johnson M, et al. The impact of cognitive impairment on self-management in chronic obstructive pulmonary disease: a systematic review. Respir Med. 2017;129:130-139.
  18. American Thoracic Society website. St. George’s Respiratory Questionnaire. Accessed January 26, 2023.
  19. Centers for Medicare & Medicaid Services. MLN Matters. Number MM8304. Published July 1, 2013. Accessed May 24, 2023.
  20. Hegewald M. Aerosol Delivery Devices for Obstructive Lung Disease: Focus on Nebulizer Systems. Accessed January 26, 2023.